Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Corydalin: ACAT inhibitor from natural source

May 10, 1996

Bone-regulatory activity of oncostatin M reported

May 10, 1996

F-792: Truncated oxytocin analogue from Ferring

May 3, 1996

Testosterone enanthate effective in male contraception study

May 3, 1996

Seprafilm approval recommended in U.S.

May 3, 1996

Genistein claimed for menopausal and PMS symptoms

May 3, 1996

Crinone pivotal study results publicized

May 3, 1996

Harvard Scientific files IND for impotency treatment

May 3, 1996

Progenitor delves into leptin receptor research

May 3, 1996

Redux cleared for marketing in U.S.

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...